CLINICAL_TRIALS
trial_result
· 2016-11-02
Clinical Trial Update: A Multiple Ascending Dose Study of RO4998452 in Patients With Type 2 Diabetes Mellitus. [Phase 1]
Summary
A completed Phase 1 multiple ascending dose study of Roche compound RO4998452 in patients with Type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 1 | Status: COMPLETED